Patents Assigned to Coherus Biosciences, Inc.
  • METHOD OF MANUFACTURING A PROTEIN BY PERFUSION IN MEDIA WITH A LOW AMINO ACID CONCENTRATION
    Publication number: 20180346550
    Abstract: Perfusion media are disclosed providing excellent cell density, titer and product quality for production of a therapeutic protein in a perfusion process.
    Type: Application
    Filed: August 13, 2018
    Publication date: December 6, 2018
    Applicant: Coherus Biosciences, Inc.
    Inventors: Ela PUCHACZ, James Russell GROVE
  • Method of manufacturing a protein by perfusion in media with a low amino acid concentration
    Patent number: 10047141
    Abstract: Perfusion media are disclosed providing excellent cell density, titer and product quality for production of a therapeutic protein in a perfusion process.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: August 14, 2018
    Assignee: Coherus Biosciences, Inc.
    Inventors: Ela Puchacz, James Russell Grove
  • Etanercept formulations stabilized with combinations of sugars and polyols
    Patent number: 9943601
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: April 17, 2018
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • Stable Aqueous Formulations of Adalimumab
    Publication number: 20180028655
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: October 11, 2017
    Publication date: February 1, 2018
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9861695
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: January 9, 2018
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9808525
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: November 7, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Etanercept formulations stabilized with metal ions
    Patent number: 9801942
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: October 31, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • Stable aqueous formulations of adalimumab
    Patent number: 9789185
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: October 17, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9782479
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: October 10, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9782480
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: October 10, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Etanercept formulations stabilized with xylitol
    Patent number: 9770510
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: September 26, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • Stable aqueous formulations of adalimumab
    Patent number: 9770507
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: September 26, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Perfusion method for manufacturing etanercept
    Patent number: 9765139
    Abstract: Production of etanercept using perfusion methods achieves attractive yields of properly folded protein. Desired temperature, feed media, titers and percent correctly folded protein are disclosed.
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: September 19, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Ela Puchacz, James Russell Grove
  • Stable aqueous formulations of adalimumab
    Patent number: 9757454
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: September 12, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9737600
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: August 22, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9731008
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: August 15, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9731009
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: August 15, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9724415
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: August 8, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9724414
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: August 8, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 9707293
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: July 18, 2017
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne